These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19932697)

  • 1. A novel composite immunotoxin that suppresses rabies virus production by the infected cells.
    Mareeva T; Wanjalla C; Schnell MJ; Sykulev Y
    J Immunol Methods; 2010 Feb; 353(1-2):78-86. PubMed ID: 19932697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H; He D; Chao K; Lin Q; You S; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):348-51. PubMed ID: 15971603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
    Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
    Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE; Xiang L; Chertov O; Margulies I; Kreitman RJ; FitzGerald DJ; Pastan I
    Blood; 2009 Apr; 113(16):3792-800. PubMed ID: 18988862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z; Feng Z; Zhu X; Xu W; Zhu J; Zhang X; Fan Z; Ji G
    Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK; Huhn M; Thepen T; Stöcker M; Krohn R; Vogel S; Jost E; Osieka R; van de Winkel JG; Fischer R; Finnern R; Barth S
    Cancer Res; 2003 Dec; 63(23):8414-9. PubMed ID: 14679004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK; Williams-Gould J; Beers R; Chowdhury P; Pastan I
    Mol Cancer Ther; 2001 Dec; 1(2):79-84. PubMed ID: 12467225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.).
    Mirzaee M; Jalali-Javaran M; Moieni A; Zeinali S; Behdani M
    Plant Mol Biol; 2018 May; 97(1-2):103-112. PubMed ID: 29633168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M
    Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
    Schwemmlein M; Peipp M; Barbin K; Saul D; Stockmeyer B; Repp R; Birkmann J; Oduncu F; Emmerich B; Fey GH
    Br J Haematol; 2006 Apr; 133(2):141-51. PubMed ID: 16611304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody internalization studied using a novel IgG binding toxin fusion.
    Mazor Y; Barnea I; Keydar I; Benhar I
    J Immunol Methods; 2007 Apr; 321(1-2):41-59. PubMed ID: 17336321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.
    Reiter Y; Di Carlo A; Fugger L; Engberg J; Pastan I
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4631-6. PubMed ID: 9114042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
    Choe M; Webber KO; Pastan I
    Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
    Zhao J; Sun ZW; Liu YF; Yu WY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):585-7. PubMed ID: 15182657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.
    Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I
    Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.
    Cai Y; Berger EA
    Antiviral Res; 2011 Jun; 90(3):143-50. PubMed ID: 21440007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
    Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
    ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chang J; Liu X; Ren H; Lu S; Li M; Zhang S; Zhao K; Li H; Zhou X; Peng L; Liu Z; Hu P
    Mol Pharm; 2021 Jun; 18(6):2285-2297. PubMed ID: 33998814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.
    Peipp M; Küpers H; Saul D; Schlierf B; Greil J; Zunino SJ; Gramatzki M; Fey GH
    Cancer Res; 2002 May; 62(10):2848-55. PubMed ID: 12019163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients.
    Onda M; Nagata S; FitzGerald DJ; Beers R; Fisher RJ; Vincent JJ; Lee B; Nakamura M; Hwang J; Kreitman RJ; Hassan R; Pastan I
    J Immunol; 2006 Dec; 177(12):8822-34. PubMed ID: 17142785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.